British Journal of Haematology, 0007-1048

Journal

1 - 10 out of 129Page size: 10

Publications

  1. 2019
  2. Published

    The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience

    Justin Loke, Ram Malladi, Paul Moss & Charles Craddock, 21 Dec 2019, In : British Journal of Haematology. 188, 1, p. 129-146 18 p.

    Research output: Contribution to journal › Review article

  3. E-pub ahead of print

    A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study)

    Yongzhong Sun, Andrea Roalfe, Pollyanna Hardy & David Fitzmaurice, 12 Nov 2019, In : British Journal of Haematology. 14 p.

    Research output: Contribution to journal › Article

  4. Published

    Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia

    Pamela Kearns, 1 Aug 2019, In : British Journal of Haematology. 186, 3, p. e7-e11 4 p.

    Research output: Contribution to journal › Letter

  5. Published

    The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial

    Dickens Pratt & Mark Drayson, May 2019, In : British Journal of Haematology. 185, 3, p. 450-467 18 p.

    Research output: Contribution to journal › Article

  6. Published

    A rare complication of bone marrow aspiration and trephine biopsy: staphylococcus aureus osteomyelitis and septicaemia

    Paul Moss, 1 Jan 2019, In : British Journal of Haematology. 184, 1, p. 7 1 p.

    Research output: Contribution to journal › Article

  7. 2018
  8. E-pub ahead of print

    Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults

    Sylvie Freeman, 5 Dec 2018, In : British Journal of Haematology. 4 p.

    Research output: Contribution to journal › Letter

  9. Published

    A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma

    Christina Yap, Ceri Oldreive, Daniel Slade, Paul Moss & Tatjana Stankovic, Aug 2018, In : British Journal of Haematology. 182, 3, p. 429-433

    Research output: Contribution to journal › Letter

  10. E-pub ahead of print

    Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline

    Helen Parry, 15 Jul 2018, In : British Journal of Haematology. 182, 3, p. 344-359 16 p.

    Research output: Contribution to journal › Article

  11. 2017
  12. Published

    Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests

    Jennifer Heaney, John Campbell, Ann Griffin, Jane Birtwistle & Mark Drayson, Jul 2017, In : British Journal of Haematology. 178, 2, p. 220-230

    Research output: Contribution to journal › Article

  13. Published

    Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

    Charles Craddock & 2 others, , Jun 2017, In : British Journal of Haematology. 177, 5, p. 759-765 7 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 ...13 Next